FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2972393619> ?p ?o ?g. }

• W2972393619 endingPage "175628481987492" @default.
• W2972393619 startingPage "175628481987492" @default.
• W2972393619 abstract "Empirical therapy of Helicobacter pylori frequently results in treatment failure due to unrecognized antimicrobial resistance. The aim of this study was to investigate the effectiveness of susceptibility-guided therapy for rescue treatment of H. pylori infection in China.This was a prospective study of consecutive 200 patients infected with H. pylori with one or more treatment failures. The therapy chosen was susceptibility based using the most effective, best-tolerated regimens first and a locally proven, reliably effective regimen for multidrug-resistant infections. All patients received 14-day triple therapy, i.e. esomeprazole 20 mg and amoxicillin 1 g twice a day plus clarithromycin 500 mg twice a day, metronidazole 400 mg twice a day, or levofloxacin 500 mg daily, or, for multidrug-resistant infections, amoxicillin-containing bismuth quadruple therapy with esomeprazole 20 mg twice a day, bismuth 220 mg twice a day, amoxicillin 1 g three times a day, and metronidazole 400 mg four times a day. Antibiotic resistance was determined by agar dilution.The eradication rate of susceptibility-guided therapy overall was 94.5% (189/200, 95% confidence interval: 90.4-97.2%). Around 28% (56/200) of patients carried strains susceptible to one of the tested antibiotics and were prescribed the triple therapy. A total of 144 multidrug-resistant patients received bismuth quadruple therapy. The eradication rates were all greater than 90%, i.e. 91.7% (11/12), 92.3% (12/13), and 93.5% (29/31) in those who received clarithromycin, metronidazole, and levofloxacin-containing triple therapy and 95.1% (137/144) for the bismuth quadruple therapy. There were no differences in eradication rates between the subgroups.Although susceptibility-guided therapy proved high efficacious despite the high proportion of multidrug-resistant strains, the strategy suggested the best approach for this population would be empirical amoxicillin-containing bismuth quadruple therapy. ClinicalTrials.gov identifier: NCT03413020." @default.
• W2972393619 created "2019-09-19" @default.
• W2972393619 creator A5000645986 @default.
• W2972393619 creator A5006667126 @default.
• W2972393619 creator A5015124962 @default.
• W2972393619 creator A5034828053 @default.
• W2972393619 creator A5034900535 @default.
• W2972393619 creator A5053029021 @default.
• W2972393619 creator A5053556585 @default.
• W2972393619 creator A5062871068 @default.
• W2972393619 creator A5079691548 @default.
• W2972393619 creator A5081392288 @default.
• W2972393619 date "2019-01-01" @default.
• W2972393619 modified "2023-09-28" @default.
• W2972393619 title "Susceptibility-guided therapy for <i>Helicobacter pylori</i> infection treatment failures" @default.
• W2972393619 cites W1989052063 @default.
• W2972393619 cites W2003100889 @default.
• W2972393619 cites W2029646359 @default.
• W2972393619 cites W2032011392 @default.
• W2972393619 cites W2044682808 @default.
• W2972393619 cites W2056606483 @default.
• W2972393619 cites W2059285031 @default.
• W2972393619 cites W2128624383 @default.
• W2972393619 cites W2143818784 @default.
• W2972393619 cites W2158672553 @default.
• W2972393619 cites W2159423500 @default.
• W2972393619 cites W2401958031 @default.
• W2972393619 cites W2525765979 @default.
• W2972393619 cites W2527848138 @default.
• W2972393619 cites W2531963478 @default.
• W2972393619 cites W2604444005 @default.
• W2972393619 cites W2608096504 @default.
• W2972393619 cites W2739167095 @default.
• W2972393619 cites W2751252352 @default.
• W2972393619 cites W2780245653 @default.
• W2972393619 cites W2782293204 @default.
• W2972393619 cites W2790522681 @default.
• W2972393619 cites W2791122834 @default.
• W2972393619 cites W2792934812 @default.
• W2972393619 cites W2805574802 @default.
• W2972393619 cites W2809819435 @default.
• W2972393619 cites W2881320234 @default.
• W2972393619 cites W2901185013 @default.
• W2972393619 doi "https://doi.org/10.1177/1756284819874922" @default.
• W2972393619 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6734621" @default.
• W2972393619 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31523279" @default.
• W2972393619 hasPublicationYear "2019" @default.
• W2972393619 type Work @default.
• W2972393619 sameAs 2972393619 @default.
• W2972393619 citedByCount "26" @default.
• W2972393619 countsByYear W29723936192020 @default.
• W2972393619 countsByYear W29723936192021 @default.
• W2972393619 countsByYear W29723936192022 @default.
• W2972393619 countsByYear W29723936192023 @default.
• W2972393619 crossrefType "journal-article" @default.
• W2972393619 hasAuthorship W2972393619A5000645986 @default.
• W2972393619 hasAuthorship W2972393619A5006667126 @default.
• W2972393619 hasAuthorship W2972393619A5015124962 @default.
• W2972393619 hasAuthorship W2972393619A5034828053 @default.
• W2972393619 hasAuthorship W2972393619A5034900535 @default.
• W2972393619 hasAuthorship W2972393619A5053029021 @default.
• W2972393619 hasAuthorship W2972393619A5053556585 @default.
• W2972393619 hasAuthorship W2972393619A5062871068 @default.
• W2972393619 hasAuthorship W2972393619A5079691548 @default.
• W2972393619 hasAuthorship W2972393619A5081392288 @default.
• W2972393619 hasBestOaLocation W29723936191 @default.
• W2972393619 hasConcept C126322002 @default.
• W2972393619 hasConcept C176947019 @default.
• W2972393619 hasConcept C2776409635 @default.
• W2972393619 hasConcept C2776962512 @default.
• W2972393619 hasConcept C2777396551 @default.
• W2972393619 hasConcept C2778204628 @default.
• W2972393619 hasConcept C2779708577 @default.
• W2972393619 hasConcept C2780493024 @default.
• W2972393619 hasConcept C2781276175 @default.
• W2972393619 hasConcept C2781413609 @default.
• W2972393619 hasConcept C500440147 @default.
• W2972393619 hasConcept C501593827 @default.
• W2972393619 hasConcept C71924100 @default.
• W2972393619 hasConcept C86803240 @default.
• W2972393619 hasConcept C89423630 @default.
• W2972393619 hasConcept C90924648 @default.
• W2972393619 hasConceptScore W2972393619C126322002 @default.
• W2972393619 hasConceptScore W2972393619C176947019 @default.
• W2972393619 hasConceptScore W2972393619C2776409635 @default.
• W2972393619 hasConceptScore W2972393619C2776962512 @default.
• W2972393619 hasConceptScore W2972393619C2777396551 @default.
• W2972393619 hasConceptScore W2972393619C2778204628 @default.
• W2972393619 hasConceptScore W2972393619C2779708577 @default.
• W2972393619 hasConceptScore W2972393619C2780493024 @default.
• W2972393619 hasConceptScore W2972393619C2781276175 @default.
• W2972393619 hasConceptScore W2972393619C2781413609 @default.
• W2972393619 hasConceptScore W2972393619C500440147 @default.
• W2972393619 hasConceptScore W2972393619C501593827 @default.
• W2972393619 hasConceptScore W2972393619C71924100 @default.
• W2972393619 hasConceptScore W2972393619C86803240 @default.
• W2972393619 hasConceptScore W2972393619C89423630 @default.
• W2972393619 hasConceptScore W2972393619C90924648 @default.

• next